News

This new article publication from Acta Pharmaceutica Sinica B, discusses how single-cell RNA sequencing reveals that Shen-Bai ...
Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...
The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...
Elliot Godfrey, from Waddesdon in Buckinghamshire, suddenly began experiencing migraines in March following a family holiday ...
Germany has become one of the world’s leading destinations for advanced cancer care, offering cutting-edge therapies, ...
The roles of the ImP in normal immune functions includes increased MHC-I presentation, immunopeptidome diversification, T cell activation, increased differentiation of CD4+ T cells into Th1 or Th17 ...
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated ...
Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...
Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...
ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...